e-learning
resources
ERJ
2011
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?
Ling D.I., Pai M., Davids V., Brunet L., Lenders L., Meldau R., Calligaro G., Allwood B., van Zyl-Smit R., Peter J., Bateman E., Dawson R., Dheda K.
Source:
Eur Respir J 2011; 38: 649-656
Journal Issue:
September
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ling D.I., Pai M., Davids V., Brunet L., Lenders L., Meldau R., Calligaro G., Allwood B., van Zyl-Smit R., Peter J., Bateman E., Dawson R., Dheda K.. Are interferon- gamma release assays useful for diagnosing active tuberculosis in a high-burden setting?. Eur Respir J 2011; 38: 649-656
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Debate -Tuberculosis: Rolling out of new drugs without diagnostic capacities
Panel discussion on unprecedented progress in shortening treatment for TB: Evidence to date, and future possibilities
Related content which might interest you:
New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005
Comparison of two commercial interferon-γ assays for diagnosing Mycobacterium tuberculosis infection
Source: Eur Respir J 2006; 28: 24-30
Year: 2006
Direct costs of three models for the screening of latent tuberculosis infection
Source: Eur Respir J 2006; 28: 45-50
Year: 2006
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2011; 39: 163-171
Year: 2012
Interferon release does not add discriminatory value to smear-negative HIV–tuberculosis algorithms
Source: Eur Respir J 2012; 39: 163-171
Year: 2012
Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients
Source: Eur Respir J 2006; 28: 31-34
Year: 2006
Microbiology of
Mycobacterium tuberculosis
and a new diagnostic test for TB
Source: Eur Respir Mon 2012; 58: 1-13
Year: 2012
Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007
Multiple cytokine response to
mycobacterium tuberculosis
with a whole blood assay is useful to distinguish active from latent tuberculosis infection in a highly tuberculosis endemic country
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 2
Year: 2014
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Source: Eur Respir J 2006; 28: Suppl. 50, 139s
Year: 2006
Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis
Source: Eur Respir J 2007; 30: 722-728
Year: 2007
Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay
Source: Eur Respir J 2007; 29: 1212-1216
Year: 2007
Evaluation of the accuracy of several immune experimental diagnostic tools to distinguish active tuberculosis from latent infection
Source: International Congress 2015 – Science and biomarkers in TB
Year: 2015
The role of quantiferon tuberculosis gold test (Q) in diagnosing active tuberculosis (TB) and latent tuberculosis infection (LTI) in children
Source: Annual Congress 2008 - New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment
Year: 2008
Interferon-? release assays for the diagnosis of latent Mycobacterium tuberculosis infection
Source: Eur Respir J 2011; 38: 1238-1239
Year: 2011
A T-cell-based assay for rapid diagnosis of difficult cases of tuberculosis (TB): smear negative pulmonary and extra-pulmonary TB
Source: Eur Respir J 2005; 26: Suppl. 49, 240s
Year: 2005
Glycopeptidolipids for evaluating the role of non-tuberculous mycobacteria in latent tuberculosis infection diagnosis
Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management
Year: 2013
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009
Contribution of the T-SPOT.TB assay for detection of latent tuberculous infection (LTBI) in contact tracing procedures
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006
Role of 2-month sputum smears in predicting culture conversion in pulmonary tuberculosis
Source: Eur Respir J 2011; 37: 376
Year: 2011
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept